Constructive Uses For Biomarker Testing In Dementia Overview The Investigating the Impact of Alzheimer’s Disease Diagnostics in British Columbia (IMPACT-AD BC) study aimed to evaluate the effects of Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker testing on medical decision-making, personal decision-making, and health system economics. This observational, longitudinal cohort study enrolled 149
Tag: Alzheimer’s disease biomarker testing
